» Articles » PMID: 15673785

Effects of Cetylpyridinium Chloride Resistance and Treatment on Fluconazole Activity Versus Candida Albicans

Overview
Specialty Pharmacology
Date 2005 Jan 28
PMID 15673785
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Mouthwash antiseptic cetylpyridinium chloride (CPC) has potent activity against Candida albicans; however, two of five azole-resistant strains showed reduced CPC susceptibility. To further examine the potential for cross-resistance, CPC-resistant mutants were selected in vitro and their fluconazole susceptibility was tested. MICs were unchanged, and trailing growth generally decreased. With CPC-fluconazole combinations, both antagonism and synergism were observed, which can be explained, in part, by CDR1-CDR2 multidrug transporter upregulation.

Citing Articles

Sub-Therapeutic Concentrations of Hexetidine Induce Virulence Gene Expression in .

Uygun-Can B, Kadir T Infect Drug Resist. 2025; 18:875-885.

PMID: 39967831 PMC: 11834732. DOI: 10.2147/IDR.S498943.


Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of Candida albicans Vascular Catheter Infection and Candida auris Skin Colonization.

Beattie S, Esan T, Zarnowski R, Eix E, Nett J, Andes D Antimicrob Agents Chemother. 2023; 67(5):e0008123.

PMID: 37097144 PMC: 10190616. DOI: 10.1128/aac.00081-23.


Novel keto-alkyl-pyridinium antifungal molecules active in models of in vivo vascular catheter infection and ex vivo skin colonization.

Beattie S, Esan T, Zarnowski R, Eix E, Nett J, Andes D bioRxiv. 2023; .

PMID: 36711909 PMC: 9882332. DOI: 10.1101/2023.01.19.524835.


Novel Colloidal Nanocarrier of Cetylpyridinium Chloride: Antifungal Activities on Species and Cytotoxic Potential on Murine Fibroblasts.

Araujo H, Arias L, Caldeirao A, Assumpcao L, Morceli M, de Souza Neto F J Fungi (Basel). 2020; 6(4).

PMID: 33053629 PMC: 7712500. DOI: 10.3390/jof6040218.

References
1.
Fraise A . Biocide abuse and antimicrobial resistance--a cause for concern?. J Antimicrob Chemother. 2001; 49(1):11-2. DOI: 10.1093/jac/49.1.11. View

2.
Perea S, Lopez-Ribot J, Kirkpatrick W, McAtee R, Santillan R, Martinez M . Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2001; 45(10):2676-84. PMC: 90716. DOI: 10.1128/AAC.45.10.2676-2684.2001. View

3.
Russell A . Mechanisms of antimicrobial action of antiseptics and disinfectants: an increasingly important area of investigation. J Antimicrob Chemother. 2002; 49(4):597-9. DOI: 10.1093/jac/49.4.597. View

4.
White T, Holleman S, Dy F, Mirels L, Stevens D . Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother. 2002; 46(6):1704-13. PMC: 127245. DOI: 10.1128/AAC.46.6.1704-1713.2002. View

5.
Smith W, Edlind T . Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob Agents Chemother. 2002; 46(11):3532-9. PMC: 128736. DOI: 10.1128/AAC.46.11.3532-3539.2002. View